Xylem Inc.XYLNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank92
3Y CAGR+1.1%
5Y CAGR+11.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+1.1%/yr
Quarterly compound
5Y CAGR
+11.6%/yr
Recent deceleration
Percentile
P92
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.38% |
| Q3 2025 | -10.34% |
| Q2 2025 | 3.57% |
| Q1 2025 | -3.45% |
| Q4 2024 | 5.45% |
| Q3 2024 | -5.17% |
| Q2 2024 | -1.69% |
| Q1 2024 | -1.67% |
| Q4 2023 | -1.64% |
| Q3 2023 | 5.17% |
| Q2 2023 | 9.43% |
| Q1 2023 | -1.85% |
| Q4 2022 | 14.89% |
| Q3 2022 | -11.32% |
| Q2 2022 | 1.92% |
| Q1 2022 | 0.00% |
| Q4 2021 | 6.12% |
| Q3 2021 | -7.55% |
| Q2 2021 | 6.00% |
| Q1 2021 | 2.04% |
| Q4 2020 | 8.89% |
| Q3 2020 | 2.27% |
| Q2 2020 | -10.20% |
| Q1 2020 | 0.00% |
| Q4 2019 | 11.36% |
| Q3 2019 | -6.38% |
| Q2 2019 | -7.84% |
| Q1 2019 | -1.92% |
| Q4 2018 | 13.04% |
| Q3 2018 | -8.00% |
| Q2 2018 | 21.95% |
| Q1 2018 | -16.33% |
| Q4 2017 | 8.89% |
| Q3 2017 | 2.27% |
| Q2 2017 | 4.76% |
| Q1 2017 | 20.00% |
| Q4 2016 | 52.17% |
| Q3 2016 | -14.81% |
| Q2 2016 | 8.00% |
| Q1 2016 | 4.17% |